MyFinsight
Home
Blog
About
Ernexa Therapeutics Inc. (ERNA)
Ernexa Therapeutics Inc. (ERNA)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Subscribe for Financial Insights
Page 1
123
Page 1
Financial Ratios
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Free Cash flow
-4,155
-2,266
-1,163
-1,294
Return on Equity
-125.531
-80.274
-62.932
-34.734
Net Profit Margin
-
-
-
-
Debt to Asset Ratio
49.327
34.943
58.845
42.158
Quick Ratio
201.023
289.152
100.642
157.603
Current Ratio
201.023
289.152
100.642
157.603
Page 1
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Show more